Skip to main content

Want a detailed portfolio tracker?

Longeveron (LGVN) P/E (2021 - 2026)

Longeveron (LGVN) P/E from Feb 12, 2021 to Jul 21, 2026. The TTM Longeveron (LGVN) P/E is -0.53. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Longeveron (LGVN)

YearP/EChange
2026-0.53+35.91%
2025-0.39-38.43%
2024-0.63-56.26%
2023-1.44-60.11%
2022-3.62-73.02%
2021-13.43N/A

Comparison Longeveron (LGVN) P/E with competitors

Longeveron (LGVN) P/E is -0.53.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.32%
NBYStablecoin Development Corp0.00-100.81%
ENLVEnlivex Ltd0.07-114.14%
FGENFibroGen Inc0.24-145.39%
CHRSCoherus Biosciences Inc0.85-260.45%
FBIOFortress Biotech Inc0.95-279.45%
ORMPOramed Pharmaceuticals Inc1.50-384.21%
AGENAgenus Inc3.01-669.07%
INVAInnoviva Inc3.15-696.38%
VXRTVaxart Inc3.55-771.20%
CRMDCorMedix Inc3.63-786.08%
CVACCureVac N.V.4.45-940.61%
GLPGGalapagos NV4.86-1018.74%
SRPTSarepta Therapeutics Inc4.88-1023.13%
ABEOAbeona Therapeutics Inc5.39-1118.70%
ABUSArbutus Biopharma Corp5.60-1158.05%
ZVRAZevra Therapeutics Inc5.89-1213.19%
SPROSpero Therapeutics Inc6.23-1277.71%
CGENCompugen Ltd6.31-1293.87%
RIGLRigel Pharmaceuticals6.87-1399.41%
SLXNSilexion Therapeutics Corp7.30-1479.58%
OMEROmeros Corporation9.26-1850.70%
AUPHAurinia Pharmaceuticals Inc9.58-1912.38%
PLXProtalix BioTherapeutics Inc10.89-2159.33%
ACADAcadia Pharmaceuticals Inc11.73-2317.70%
TBPHTheravance Biopharma Inc12.26-2418.60%
ADMAAdma Biologics Inc12.42-2448.10%
HRMYHarmony Biosciences Holdings Inc13.82-2713.20%
SABSSAB Biotherapeutics Inc14.14-2772.96%
NAGENiagen Bioscience Inc14.82-2901.90%
INCYIncyte Corp15.82-3091.82%
REGNRegeneron Pharmaceuticals Inc15.86-3098.27%
PBYIPuma Biotechnology Inc17.32-3374.16%
CPRXCatalyst Pharmaceuticals Inc17.44-3397.53%
EXELExelixis Inc17.54-3416.19%
TGTXTG Therapeutics Inc18.97-3686.22%
MDXGMimedx Group Inc20.55-3986.19%
XOMAXOMA Royalty Corp22.87-4425.40%
ARGXArgen X SE24.30-4694.53%
CTMXCytomX Therapeutics Inc24.82-4793.45%
XOMAOXOMA Royalty Corp25.34-4892.48%
HALOHalozyme Therapeutics Inc25.62-4945.21%
XOMAPXOMA Royalty Corp25.67-4953.99%
VRTXVertex Pharmaceuticals Inc27.99-5393.55%
RPRXRoyalty Pharma plc - Class A28.69-5524.56%
SLNOSoleno Therapeutics Inc29.02-5586.54%
ASNDAscendis Pharma A/S30.09-5788.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-7268.82%
APLSApellis Pharmaceuticals Inc39.02-7478.56%
BMRNBiomarin Pharmaceutical Inc42.21-8081.88%
KRYSKrystal Biotech Inc45.34-8674.05%
ONCBeiGene Ltd69.54-13249.48%
PHARPharming Group N.V.75.03-14286.67%
TECHBio-Techne Corp101.96-19379.43%
VCELVericel Corp109.92-20885.16%
ALNYAlnylam Pharmaceuticals Inc117.96-22406.16%
GMABGenmab140.29-26627.75%
TLXTelix Pharmaceuticals Ltd162.15-30761.67%
CORTCorcept Therapeutics Inc212.86-40349.48%